Apyx Medical Corp
APYX· Nasdaq
APYXApyx Medical Corp
Filed May 15, 2013 · 10-Q · 45 days after period end · 0001140361-13-020761
| Metric | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|
| Revenue | $5.70M | $6.73M | $6.16M |
| Net Income | -$409.00K | $187.00K | $492.00K |
| EPS Diluted | -$0.02 | $0.01 | $0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Apyx Medical Corp · CIK 719135 · Engraved from SEC EDGAR
ended Mar 31, 2013 · filed May 15, 2013 · 45 d after period end
